Quarterly report pursuant to Section 13 or 15(d)

BASIC AND DILUTED EARNINGS PER SHARE

v3.19.2
BASIC AND DILUTED EARNINGS PER SHARE
6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
BASIC AND DILUTED EARNINGS PER SHARE BASIC AND DILUTED EARNINGS PER SHARE
The following table is a reconciliation of the numerator and denominators used in the earnings per share calculation:

For the Three Months Ended June 30, 
2019 2018
Income (Numerator)  Weighted Average Shares (Denominator)  Per-Share
Amount 
Income (Numerator)  Weighted Average Shares (Denominator)  Per-Share
Amount 
Basic EPS
Net income available to common stockholders $ 985,504  47,348,137  $ 0.02  $ 1,714,267  48,266,199  $ 0.04 
Effect of Dilutive Securities
Stock options & RSUs —  776,071  —  829,376 
Diluted EPS
Net income available to common stockholders + assumed conversions $ 985,504  48,124,208  $ 0.02  $ 1,714,267  49,095,575  $ 0.03 

Options to purchase 244,600 shares of common stock at a weighted average price of $3.88 per share were outstanding during the three months ended June 30, 2019, but were not included in the computation of diluted EPS because the impact of these shares would be antidilutive. These options, which expire between November 2019 and May 2020, were still outstanding at June 30, 2019. No shares were excluded for the three months ended June 30, 2018.


For the Six Months Ended June 30, 
2019 2018
Income (Numerator)  Weighted Average Shares (Denominator)  Per-Share
Amount 
Income (Numerator)  Weighted Average Shares (Denominator)  Per-Share
Amount 
Basic EPS 
Net income available to common stockholders  $ 2,654,122  47,392,534  $ 0.06  $ 3,590,498  48,467,136  $ 0.07 
Effect of Dilutive Securities 
Stock options & RSUs  —  800,315  —  770,802 
Diluted EPS 
Net income available to common stockholders + assumed conversions  $ 2,654,122  48,192,849  $ 0.06  $ 3,590,498  49,237,938  $ 0.07 
Options to purchase 244,600 and 251,600 shares of common stock at a weighted average price of $3.88 and $3.89 per share were outstanding during the six months ended June 30, 2019 and 2018, respectively, but were not included in the computation of diluted EPS because the impact of these shares would be antidilutive. These options, which expire between November 2019 and May 2020, were still outstanding at June 30, 2019.